FRONT PEDIATR 润色咨询

Frontiers in Pediatrics

出版年份:暂无数据 年文章数:5128 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:3.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-11-21 ms6000002066670259

    审稿速度:3.0 | 投稿命中率:95.0
    经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-11-18 ms9000000469362720

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:基础;临床
    经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-11-10 146a5bbem30暂无昵称

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-11-10 148763b0m69(暂无昵称)

    这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-10-20 148763b0m69(暂无昵称)

    已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-10-14 ms5000000559194097

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:儿科麻醉学
    经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了
    但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-10-11 ms2000001575364439

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-10-07 ms6000002066670259

    8月初投稿,快两个月了还在外审

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2021-05-12 443516862

    审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0
    偏重的研究方向:新生儿
    经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。

    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2101757, encodeId=88682101e5756, content=审稿速度:3.0 | 投稿命中率:95.0<br>经验分享:第一次投外国期刊,8越中旬投稿,11月初反意见,修改后当天录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Mon Nov 21 13:34:49 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101234, encodeId=cfb2210123409, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:基础;临床<br>经验分享:我写的是综述,感觉要求还是很严的。审稿人都是大佬,编辑是发了数篇顶刊的大佬,看问题一针见血。我大修好几轮,很仁慈,给你反复修稿的机会。但是确实修稿很严格,这是不会被预警的期刊,儿科小类Q1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d7b8208694, createdName=ms9000000469362720, createdTime=Fri Nov 18 00:45:45 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099690, encodeId=5450209969057, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5035155450, createdName=146a5bbem30暂无昵称, createdTime=Thu Nov 10 17:13:17 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099535, encodeId=2afe209953581, content=这个杂志怎么这么乌龙,前一周还发邮件说另一个审稿人一个半月了还找不到让推荐,下一周回来的审稿意见和文章八杆子打不着,发邮件也不回复,关键论坛还开放了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Nov 10 07:30:32 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095026, encodeId=7e5e2095026fd, content=已经有一个审稿意见,但是history动态没有变化,有遇到类似状况的小伙伴吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80095305318, createdName=148763b0m69(暂无昵称), createdTime=Thu Oct 20 19:54:46 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093787, encodeId=36852093e87b8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:儿科麻醉学<br>经验分享:我这篇审稿速度挺快的,7.19投稿,8.6两位审稿人意见都回来了,8.9开启互动评论,审稿人1第一轮直接同意发表,审稿人2提了一些问题,但算是小修,要求10天内返修完毕,8.15提交返修稿,8.22编辑激活了审稿人2,审稿人2火速回复定稿,8.23同意发表,后续就是交版面费啥的,9.8就见刊了<br>但是另外一个同学7月初就投了,结果一直找不到审稿人,中间还换了审稿人,坎坎坷坷,最终9月底也顺利接收,这个期刊审稿速度还是得看编辑,有些中国编辑速度比较慢,但总体挺友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53f55630848, createdName=ms5000000559194097, createdTime=Fri Oct 14 15:54:06 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093096, encodeId=555c2093096f3, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:中了一圈frontier下来 我觉得frontier in pediatrics是frontier系列的一股清流,生信和套路基础实验哪怕够5分的工作量都是秒拒。上面的文章偏临床,质量都不错,预测影响因子还会涨。虽然国人占比高 预警的风险不大,fII预警它都不会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=392e5432198, createdName=ms2000001575364439, createdTime=Tue Oct 11 11:50:04 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092263, encodeId=203820922630d, content=8月初投稿,快两个月了还在外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8558272081, createdName=ms6000002066670259, createdTime=Fri Oct 07 12:23:19 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964962, encodeId=382e96496278, content=审稿速度:2.0 | 投稿命中率:50.0 | 版面费用:2980.0<br>偏重的研究方向:新生儿<br>经验分享:2021年,3.16投稿,4.28给一审意见,4.30修回,当天接收;5.10收到排版,5.11修回。暂时到这里,最快的一次被接收,感觉很骄傲。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=399d1389124, createdName=443516862, createdTime=Wed May 12 17:20:33 CST 2021, time=2021-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218399, encodeId=071e121839903, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:新生儿<br>经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bf06147717, createdName=ms9000002133759885, createdTime=Tue May 10 10:57:38 CST 2022, time=2022-05-10, status=1, ipAttribution=)]
    2022-05-10 ms9000002133759885

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:新生儿
    经验分享:求助:两个外审,一个同意一个不同意,最后结果可能性怎样,好着急……

    3

    展开3条回复
共106条页码: 2/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分